Search

Fasenra

Fasenra

Manufacturer:

AstraZeneca

Distributor:

Zuellig
/
Four Star
Concise Prescribing Info
Contents
Benralizumab
Indications/Uses
Add-on maintenance treatment in adults w/ severe eosinophilic asthma inadequately controlled despite high-dose inhaled corticosteroids plus long-acting β-agonists.
Click to view Fasenra detailed prescribing information
Dosage/Direction for Use
SC 30 mg every 4 wk for the 1st 3 doses, then every 8 wk thereafter.
Click to view Fasenra detailed prescribing information
Overdosage
View Fasenra overdosage for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity.
Click to view Fasenra detailed prescribing information
Special Precautions
Hypersensitivity reactions (eg, urticaria, papular urticaria, rash) following administration. Do not inj into areas w/ tender, bruised, erythematous, or hardened skin. Should not be used to treat acute asthma exacerbations; seek medical advice if asthma remains uncontrolled or worsens after treatment initiation. Not recommended to abruptly discontinue corticosteroids after initiation of Fasenra therapy; patients w/ pre-existing helminth infections. Preferable to avoid use during pregnancy. Lactation. Childn 6-18 yr.
Click to view Fasenra detailed prescribing information
Adverse Reactions
Pharyngitis; hypersensitivity reactions; headache; pyrexia, inj site reaction.
Click to view Fasenra detailed prescribing information
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Fasenra detailed prescribing information
Storage
View Fasenra storage conditions for details to ensure optimal shelf-life.
Description
View Fasenra description for details of the chemical structure and excipients (inactive components).
Action
View Fasenra mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Antiasthmatic & COPD Preparations
ATC Classification
R03DX10 - benralizumab ; Belongs to the class of other systemic drugs used in the treatment of obstructive airway diseases.
Presentation/Packing
Form
Fasenra soln for inj 30 mg/mL (pre-filled pen)
Packing/Price
1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in